Laurel Wealth Advisors (California)’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
FAM
CIP
FLAM
CS
Laurel Wealth Advisors (California)'s ATRC Position: Q2 2022 in Review
Laurel Wealth Advisors (California) sold out of AtriCure (ATRC) in Q2 2022, closing a stake of 4,851 shares — an estimated $318K sold.
Laurel Wealth Advisors (California) first reported a position in ATRC in Q4 2021 and held it in 2 quarters. The position peaked at $318K in Q1 2022. 213 funds tracked by Wall St. Rank hold ATRC as of Q2 2022.
- Laurel Wealth Advisors (California) reported no remaining AtriCure position as of Q2 2022 after selling out during the quarter.
- Laurel Wealth Advisors (California) sold 4,851 AtriCure shares in Q2 2022, an estimated $318K.
- Laurel Wealth Advisors (California) first reported a position in AtriCure in Q4 2021 and held it in 2 quarters.
- Laurel Wealth Advisors (California)'s AtriCure position peaked at $318K in Q1 2022.
- 213 funds tracked by Wall St. Rank held AtriCure as of Q2 2022.
Based on Laurel Wealth Advisors (California)'s 13F filing for Q2 2022, filed 12 Aug 2022.